---
name: Ascendiacdmo
slug: ascendiacdmo
site: cdmo
website_domain: ascendiacdmo.com
summary: Ascendia is a specialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules, biologics, and gene delivery therapies, with proprietary nanotechnologies for solubility and bioavailability enhancement. Headquartered in New Jersey, United States.
tagline: Specialty CDMO solving solubility and bioavailability challenges with proprietary nanotechnologies.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-07-30T03:52:27.838Z
services_count: 11
modalities_count: 3
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Ascendiacdmo

Specialty CDMO solving solubility and bioavailability challenges with proprietary nanotechnologies.

Listed on cdmo.directory.

## Summary

Ascendia is a specialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules, biologics, and gene delivery therapies, with proprietary nanotechnologies for solubility and bioavailability enhancement. Headquartered in New Jersey, United States.

## At a glance

- HQ country: US

## Services

- Formulation Development
- CMC Analytical Development
- Stability Testing & Storage
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support
- Oral Solid Dosage Manufacturing
- Lyophilization (Freeze Drying)
- Vial Filling
- Sterile Fill-Finish & Aseptic Manufacturing
- Prefilled Syringe (PFS) Filling

## Modalities

- Small Molecule
- Biologics (Other)
- Gene Therapy

## Locations

- Headquarters & Manufacturing, New Jersey, New Jersey, United States

## Long description

## Overview

Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) providing comprehensive services from pre-formulation through commercialization. The company specializes in solving complex drug delivery challenges using proprietary nanotechnologies and sophisticated formulation approaches.

## Core Capabilities

**Formulation & Technologies:**
- Four patented nanotechnologies: LipidSol (lipid nanoparticles), EmulSol (nano/micro-emulsions), AmorSol (amorphous solid dispersions), and NanoSol (nano-sized particles)
- Pre-formulation and formulation development for poorly soluble compounds
- Bioavailability enhancement and controlled/modified release dosage forms
- Self-Emulsifying Drug Delivery Systems (SEDDS)
- Long-acting injectables and lyophilized products

**Manufacturing:**
- Full-spectrum cGMP and GMP manufacturing for clinical trial materials and commercial supply
- Sterile injectables and oral solid dosage forms
- Nanoparticle formulations and lipid-based drug delivery systems
- Aseptic and non-aseptic manufacturing capabilities
- Support from IND-enabling batches through Phase 1–3 manufacturing

**Analytical Services:**
- ICH stability studies
- Small-scale formulation support
- Analytical method development
- Regulatory documentation preparation

## Quality & Compliance

Ascendia operates under comprehensive cGMP quality systems with electronic quality management (QMS) implementation. The company's U.S.-based facilities in the New Jersey Bioscience Center are designed for FDA compliance and undergo frequent client audits and internal quality assessments. All formulation development and manufacturing is conducted in the U.S.

## Business Model

Unlike conventional drug delivery technology companies, Ascendia operates on a straightforward fee-for-service CDMO model without technology access fees or royalties, while providing clients access to its proprietary nanotechnology platforms.

## Related companies

- [Ascendia Pharmaceutical Solutions](/companies/ascendiapharma) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/ascendiapharma)
- [Pyramid Pharma Services](/companies/pyramid-pharma-services) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/pyramid-pharma-services)
- [Delpharm](/companies/delpharm) (Formulation Development, Stability Testing & Storage) — [Compare](/compare/ascendiacdmo/delpharm)
- [Pfizer CentreOne](/companies/pfizercentreone) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/pfizercentreone)
- [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) (Formulation Development, CMC Analytical Development) — [Compare](/compare/akums/ascendiacdmo)
- [Pharmaceutics International, Inc.](/companies/pharm-int) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/pharm-int)
- [Glatt](/companies/glatt) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/glatt)
- [MyBiotech GmbH](/companies/mybiotech) (Formulation Development, CMC Analytical Development) — [Compare](/compare/ascendiacdmo/mybiotech)

_Profile last updated: 2026-07-30T03:52:27.838Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.